Article Text

024 Making anti-thrombotic bypass vessels from selected populations of vascular smooth muscle cells
  1. A A Dhanji1,
  2. F Y Ali1,
  3. L S Harrington2,
  4. A Shipolini3,
  5. J A Mitchell2,
  6. T D Warner1
  1. 1Barts and The London School of Medicine and Dentistry, London, UK
  2. 2National Heart and Lung Institute, London, UK
  3. 3Barts and The London NHS Trust, London, UK


Objectives Vein grafts are commonly used for coronary artery bypass surgery but poor long-term patency and high failure rate make the idea of ‘designer’ bypass vessels attractive. Here we have investigated the possibility of forming bypass vessels from populations of vascular smooth muscle cells (VSMCs) selected for their anti-thrombotic potential.

Methods Clonal populations of rat VSMCs were derived and characterised for their morphology, protein expression and mediator production. Selected cells were also seeded into vascular scaffolds derived by decellularising rat aortae and cultured for periods of up to 40 days.

Results Clone 5 was found to be the optimal clone due to its ability to produce the anti-platelet hormone prostaglandin (PG) I2 and inhibit platelet activation. In experiments combining the synthetic vessels with platelets, a notable inhibition of platelet activation was seen with a reduction in platelet aggregation (72±4% to 31±9%) (Abstract 024 Figure 1), adhesion (43±2% to 19±6%) (Abstract 024 Figure 2), decreased production of thromboxane A2 (58±8 ng/ml to 31±3 ng/ml) and increased prostaglandin I2 production (0.6±0.5 ng/ml to 5.5±0.8 ng/ml), in response to collagen (3 μg/ml).

Abstract 024 Figure 1

Platelet aggregation in response to collagen (3 μg/ml). Mean±SEM. n=5.

Abstract 024 Figure 2

Platelet adhesion in response to collagen (3 μg/ml). Mean±SEM. n=5.

Conclusions These results demonstrate that clonal VSMC populations with favourable characteristics, such as the production of anti-thrombotic PGI2 can be isolated and used to produce anti-thrombotic vessels. This raises the possibility of producing vessels for bypass surgery by the simple seeding of selected VSMC populations into inert vascular scaffolds.

  • anti-thrombotic
  • bypass
  • smooth muscle

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.